This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
Mark Your Calendar to Join Us Next Year September 23-26, 2024
Hynes Convention Center in BostonBoston, MA
Menu

Kate Rochlin
Chief Operating Officer at IN8bio, USA

Agenda Sessions

  • Development and Commercialization of Gamma-Delta T Cell Therapies

    , 2:00pm
    View Session

Speakers at this event

Prev
Next
Jason Rogers
Principal Scientist
STERIS

See Kate Speak